Related Experiment Video
Updated: Jun 16, 2026

14:27
Identification of Disease-related Spatial Covariance Patterns using Neuroimaging Data
Published on: June 26, 2013
15.6K
White matter biomarker for predicting de novo Parkinson's disease using tract-based spatial statistics: a machine
Qi Zhang1,2, Haoran Wang1,2, Yonghong Shi1,2
1Digital Medical Research Center, School of Basic Medical Sciences, Fudan University, Shanghai, China.
Quantitative Imaging in Medicine and Surgery
|April 15, 2024
Summary
Early Parkinson's disease (PD) detection is improved by analyzing white matter (WM) lesions using neuroimaging. This method, combined with clinical data, enhances diagnostic accuracy for early PD prediction.
Area of Science:
- Neuroimaging
- Neurology
- Biomarker Discovery
Background:
- Parkinson's disease (PD) is a chronic, neurodegenerative disorder.
- Cerebral white matter (WM) lesions are associated with PD.
- Early detection of WM alterations can aid in timely intervention.
Purpose of the Study:
- To investigate microstructural alterations in white matter (WM) in early Parkinson's disease (PD).
- To develop a predictive model for early PD diagnosis using WM lesions.
- To assess the impact of integrating clinical factors into the predictive model.
Main Methods:
- Utilized data from the Parkinson's Progression Markers Initiative (PPMI) database (152 PD patients, 75 controls).
- Performed whole-brain voxel analysis of WM using tract-based spatial statistics (TBSS).
- Employed least absolute shrinkage and selection operator (LASSO) regression and random forest (RF) algorithms for classification, with 5-fold cross-validation.
Main Results:
- PD patients showed significantly decreased fractional anisotropy (FA) values, indicating widespread WM lesions.
- The WM lesion-based PD prediction model achieved an accuracy of 0.783 and AUC of 0.831 in the test set.
- Integrating clinical factors improved the model's test set performance to 0.804 accuracy and 0.844 AUC.
Conclusions:
- Quantitative analysis of WM lesions on FA images via TBSS serves as a neuroimaging biomarker for early PD diagnosis.
- The predictive model demonstrates potential for individual-level early PD detection.
- Integration with clinical variables enhances the predictive power of the neuroimaging biomarker.

